LEI 9695000C29NCCMCASC68
OSIVAX
Contract awards & public grants
Revolutionary vaccines to prevent pandemic and seasonal outbreaks of respiratory viral infections: The best-in-class UNIVERSAL multi-season influenza → OSIVAX SAS
European Commission · FR · Grant · 2020-07-16
€2.46M
Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria → OSIVAX SAS
European Commission · FR · Grant · 2016-12-09
€35,874
Optimizing a deployable high efficacy malaria vaccine → OSIVAX SAS
European Commission · FR · Grant · 2016-12-09
€19,842
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.